We are live on ! Find out more
ACAD icon

Acadia Pharmaceuticals
ACAD

212 hedge funds and large institutions have $4.44B invested in Acadia Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

42% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 24

33% more capital invested

Capital invested by funds: $3.34B → $4.44B (+$1.1B)

4% more funds holding

Funds holding: 203 → 212 (+9)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

1.9% less ownership

Funds ownership: 98.15% → 96.25% (-1.9%)

38% less call options, than puts

Call options by funds: $44.1M | Put options by funds: $71.4M

Holders
212
Holders Change
+9
Holders Change %
+4.43%
% of All Funds
5.29%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
34
Increased
67
Reduced
72
Closed
24
Calls
$44.1M
Puts
$71.4M
Net Calls
-$27.2M
Net Calls Change
-$16.3M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$74.7M
2
BlackRock
BlackRock
New York
+$26M
3
TCIM
TIAA CREF Investment Management
New York
+$16.9M
4
TA
Teachers Advisors
New York
+$13.1M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$12.6M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$44.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$22.1M
3
SIG
Senator Investment Group
New York
-$18.1M
4
Millennium Management
Millennium Management
New York
-$17.2M
5
ACA
Avoro Capital Advisors
New York
-$17.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
101
Nationwide Fund Advisors
Ohio
$1.45M +$371K +11,410 +42%
Ohio Public Employees Retirement System (OPERS)
102
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.43M -$42.1K -1,295 -3%
SEC
103
Seven Eight Capital
New York
$1.33M +$1.15M +35,403 New
IGIM
104
I.G. Investment Management
Manitoba, Canada
$1.32M – – –
LCM
105
Legato Capital Management
California
$1.27M +$838K +25,748 +322%
N
106
Natixis
France
$1.27M +$1.09M +33,602 New
NPC
107
National Planning Corporation
California
$1.26M -$35.8K -1,100 -3%
Squarepoint
108
Squarepoint
New York
$1.25M +$1.08M +33,256 New
TD Asset Management
109
TD Asset Management
Ontario, Canada
$1.23M -$960K -29,500 -47%
PIM
110
Platinum Investment Management
Australia
$1.22M – – –
FM
111
Family Management
New York
$1.11M -$195K -6,000 -17%
Allianz Asset Management
112
Allianz Asset Management
Germany
$1.09M -$2.77K -85 -0.3%
MAP
113
Moody Aldrich Partners
Massachusetts
$1.09M +$335K +10,304 +55%
DADC
114
D.A. Davidson & Co
Montana
$1.06M +$29.3K +900 +3%
BCM
115
Bayesian Capital Management
New York
$964K +$832K +25,584 New
WMSA
116
Weiss Multi-Strategy Advisers
New York
$942K – – –
BNP Paribas Financial Markets
117
BNP Paribas Financial Markets
France
$890K +$81K +2,489 +12%
Public Employees Retirement Association of Colorado
118
Public Employees Retirement Association of Colorado
Colorado
$805K – – –
Simplex Trading
119
Simplex Trading
Illinois
$799K -$1.61M -49,457 -70%
State of Wisconsin Investment Board
120
State of Wisconsin Investment Board
Wisconsin
$740K +$17.7K +543 +3%
SEI Investments
121
SEI Investments
Pennsylvania
$737K +$83.4K +2,565 +15%
D.E. Shaw & Co
122
D.E. Shaw & Co
New York
$694K +$600K +18,429 New
SFM
123
Soros Fund Management
New York
$689K +$595K +18,300 New
AB
124
Amalgamated Bank
New York
$688K +$12.8K +392 +2%
PP
125
Paloma Partners
Connecticut
$686K +$592K +18,200 New
3 4
5
6 7

ACAD Hedge Fund Activity: Q3 2017 in Review

212 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Acadia Pharmaceuticals (ACAD) for Q3 2017, worth a combined $4.44B — up 33% from $3.34B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ACAD positions and 24 closed out — a net gain of 10 holders — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $74.7M. The largest seller was T. Rowe Price Associates, cutting an estimated $44.7M.

  • 212 institutional investors held Acadia Pharmaceuticals (ACAD) as of Q3 2017, up from 203 in Q2 2017.
  • Funds reported $4.44B of Acadia Pharmaceuticals stock for Q3 2017, up 33% quarter-over-quarter.
  • 34 funds opened new Acadia Pharmaceuticals positions in Q3 2017 and 24 closed out, a net change of +10 holders.
  • The largest Acadia Pharmaceuticals buyer in Q3 2017 was Janus Henderson Group, an estimated $74.7M added.
  • The largest Acadia Pharmaceuticals seller in Q3 2017 was T. Rowe Price Associates, an estimated $44.7M sold.

Based on aggregated 13F filings for Q3 2017.